TabsDetailsBasic DetailsDate Posted: Wednesday, March 21, 2018Status: CompleteMedical Product: carbamazepine, clozapine, lamotrigine, levetiracetam, ofatumumab, olanzapine, topiramateHealth Outcome(s): agranulocytosisDescription: This report investigated diagnosis of agranulocytosis following new use of several anti-epileptic drugs (AEDs), as well as clozapine and olanzapine. Data from January 1, 2000 to May 31, 2013 from 18 Data Partners contributing to the Mini-Sentinel Distributed Database (MSDD) were included in this request. The request was distributed to Data Partners on April 11, 2014. Read More Deliverables (2)Mini-Sentinel Modular Program Report: Diagnosis of Agranulocytosis Following New Use of AEDs, Clozapine, and Olanzapine, Report 1Mini-Sentinel Modular Program Report: Diagnosis of Agranulocytosis Following New Use of AEDs, Clozapine, and Olanzapine, Report 2Additional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2000 - May 31, 2013Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Mini-Sentinel Distributed Database (MSDD)
